The frequency of extrapulmonary TB in patients treated with antitumor necrosis factor (TNF) therapy has ranged from 28% to 75%, with most reports indicating that over 50% of cases are extrapulmonary [10, 11]. This evidence concerns the gene TNF and tuberculosis.